{"id":"556241-5322","orgnr":"556241-5322","name":"Midsona AB","name_registered_on":"2010-12-09","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"1984-02-29","business_description":"Bolaget ska direkt eller genom dotterbolag utveckla och marknadsföra hälsoprodukter, innefattande läkemedel och biotekniska produkter, naturläkemedel och kosttillskott, egenvårdsprodukter, hälsolivsmedel samt relaterade produkter, samt bedriva därmed förenlig verksamhet.","industries":[{"code":"70100","name":"Verksamheter som utövas av huvudkontor"}],"postal_address":{"city":"MALMÖ","country":"SE","municipality":{"code":"1280","name":"Malmö"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1280","name":"Malmö"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"5","name":"20-49 anställda"},"turnover_class":{"code":"7","name":"50 000 - 99 999 tkr","year":2025},"public_company":{"code":"23","name":"Publikt, Stockholm Small Cap"},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"IFRS","documents":{"annual_report":"/v1/documents/910f3c86-2683-476d-83d3-58ea23c7a129.xhtml","certificate":"/v1/documents/1825e398-2c25-424f-8530-ca833b39ccf9.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/22_2.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"IFRS","documents":{"annual_report":"/v1/documents/171cd20b-1fa3-42cd-a6fc-7af807e35fb2.xhtml","certificate":"/v1/documents/c79975ab-5134-4dfd-a5be-6b616e77f349.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/20_1.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300YMDO8YBYYI1981/2023-12-31/ESEF/SE/0/549300YMDO8YBYYI1981-2023-12-31-sv.zip","url":"https://filings.xbrl.org/549300YMDO8YBYYI1981/2023-12-31/ESEF/SE/0/549300YMDO8YBYYI1981-2023-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2022-01-01","to":"2022-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300YMDO8YBYYI1981/2022-12-31/ESEF/SE/0/549300YMDO8YBYYI1981-2022-12-31-sv.zip","url":"https://filings.xbrl.org/549300YMDO8YBYYI1981/2022-12-31/ESEF/SE/0/549300YMDO8YBYYI1981-2022-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2021-01-01","to":"2021-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300YMDO8YBYYI1981/2021-12-31/ESEF/SE/0/549300YMDO8YBYYI1981-2021-12-31-sv.zip","url":"https://filings.xbrl.org/549300YMDO8YBYYI1981/2021-12-31/ESEF/SE/0/549300YMDO8YBYYI1981-2021-12-31-sv/reports/ixbrlviewer.html"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"group","currency":"SEK","net_sales":3630000000,"operating_profit":58000000,"profit_after_financial_items":24000000,"net_profit":10000000,"total_assets":4391000000,"equity":2933000000,"long_term_liabilities":863000000,"current_liabilities":595000000,"cash":316000000,"net_sales_growth":-0.026,"source":{"annual_report":"2025-12-31","document":"/v1/documents/910f3c86-2683-476d-83d3-58ea23c7a129.xhtml"},"anchors":{"cash":{"text":"316","prefix":"28, 33"},"current_liabilities":{"text":"595"},"equity":{"text":"2 933","prefix":"22"},"long_term_liabilities":{"text":"863"},"net_profit":{"text":"10","prefix":"resultat"},"net_sales":{"text":"3 630","prefix":"3"},"operating_profit":{"text":"58","prefix":"25"},"profit_after_financial_items":{"text":"24","prefix":"skatt"},"total_assets":{"text":"4 391"}}}}